Clinical Trials
14 trialsNCT06950385 2026-06-02
SERENTA
Rapamycin Holdings Inc.
Phase 3 Recruiting
NCT05919264 2026-05-28
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Phase 1/2 Recruiting
NCT06614738 2026-05-27
Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)
Hospices Civils de Lyon
Recruiting
NCT06641310 2026-05-19
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
University of Michigan Rogel Cancer Center
Phase NA Recruiting
NCT05223036 2026-05-14
Testing Obeticholic Acid for Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Terminated
NCT05630794 2026-05-13
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT06557733 2026-05-13
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06308445 2026-05-08
RAPA-4-PAF
University Hospital, Toulouse
Phase 2 Not yet recruiting
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT06649825 2026-04-24
VitB1; FAP
Shanghai Zhongshan Hospital
Phase NA Enrolling by invitation
NCT03050268 2026-04-23
SJFAMILY
St. Jude Children's Research Hospital
Recruiting
NCT05552755 2026-04-16
TUPELO
Recursion Pharmaceuticals Inc.
Phase 1/2 Recruiting
NCT07463599 2026-03-11
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
HonorHealth Research Institute
Phase 1/2 Recruiting
NCT07461246 2026-03-10
RIPAF
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Active not recruiting